Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 1;17(12):e0278534.
doi: 10.1371/journal.pone.0278534. eCollection 2022.

Association between the Big Five personality traits and medication adherence in patients with cardiovascular disease: A cross-sectional study

Takuji Adachi  1   2 , Yuki Tsunekawa  2 , Daisuke Tanimura  3
Affiliations

Association between the Big Five personality traits and medication adherence in patients with cardiovascular disease: A cross-sectional study

Takuji Adachi et al. PLoS One. .

Abstract

The correlation between personality traits and health outcomes of primary prevention has been examined. However, there is a lack of evidence on the association between the assessment of personality traits and medication adherence for secondary prevention of cardiovascular disease. Thus, this study aimed to explore the association between personality traits and medication adherence, including compliance to prescribed medications and attitudes toward taking medications among patients with cardiovascular disease. This cross-sectional study included patients hospitalized for cardiovascular disease. We assessed the Big Five personality traits (conscientiousness, neuroticism, openness, extraversion, and agreeableness) of each patient at discharge using the Ten-Item Personality Inventory. In addition, we evaluated four aspects of medication adherence using a 12-item version of the medication adherence scale: medication compliance, collaboration with health care providers, willingness to access and use information on medication, and acceptance to take medication. Logistic regression analysis was performed to assess the correlation between the level of each medication adherence domain and each personality trait. The data of 128 patients with cardiovascular disease were analyzed. Higher conscientiousness score was significantly associated with a high compliance score (odds ratio per 1 point increase, 1.90; 95% confidence interval, 1.30-2.79; p = 0.001), high collaboration score (1.90; 1.31-2.76; p = 0.001), and high willingness score (1.74; 1.19-2.54; p = 0.004) after adjustment for potential confounders. Other combinations of personality traits and medication adherence showed no statistically significant correlations in multivariate analyses. The findings of this study suggest that assessment of personality traits, especially conscientiousness, may facilitate patient-medical staff communication for the improvement of medication adherence in patients with cardiovascular disease.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Flowchart of the study participants.
CVD, cardiovascular disease; TIPI-J, Japanese version of the Ten-Item Personality Inventory.
Fig 2
Fig 2. Results of age-adjusted logistic regression analysis.
OR, odds ratio; CI, confidence interval.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Visseren FLJ, MacH F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al.. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42: 3227–3337. doi: 10.1093/eurheartj/ehab484 - DOI - PubMed
    1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al.. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42: 3599–3726. doi: 10.1093/eurheartj/ehab368 - DOI - PubMed
    1. Brown DL. Optimal Medical Therapy as First-Line Therapy for Chronic Coronary Syndromes: Lessons from COURAGE, BARI 2D, FAME 2, and ISCHEMIA. Cardiovasc drugs Ther. 2021. doi: 10.1007/s10557-021-07289-6 - DOI - PubMed
    1. Ambrosetti M, Abreu A, Corrà U, Davos CH, Hansen D, Frederix I, et al.. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2021;28: 460–495. doi: 10.1177/2047487320913379 - DOI - PubMed
    1. Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C, et al.. Adherence to cardiovascular therapy: A meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34: 2940–2948. doi: 10.1093/eurheartj/eht295 - DOI - PubMed

Publication types